Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Dose, Uncontrolled, Open-label, One Group Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Patients With Bacterial Infections

NCT05614895 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT05614895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05614895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Dose, Uncontrolled, Open-label, One Group Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Patients With Bacterial Infections
Lead sponsor
Hoffmann-La Roche
Phase
Phase 1
Overall status
Completed
Start date
December 3, 2022
Completion date
January 13, 2024
Enrollment
48 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections